Oncology (all articles)
RCT: In patients with early-stage lung cancer, video-assisted thoracoscopic lobectomy is associated with better recovery of physical function at 5 weeks.
3 Mar, 2022 | 08:42h | UTCVideo-Assisted Thoracoscopic or Open Lobectomy in Early-Stage Lung Cancer – NEJM Evidence
Commentary on Twitter
For patients with early-stage #LungCancer, resection by video-assisted thoracoscopic surgery was superior to open resection with respect to postoperative recovery of physical function as shown in a randomized trial. @ekslim @RBandH #VATS #OncoAlert https://t.co/j23CgZp5U5 pic.twitter.com/UsIx3D8Zem
— NEJM Evidence (@NEJMEvidence) January 19, 2022
Cancer risks other than female breast and ovarian cancers associated with BRCA1 and BRCA2 pathogenic variants.
3 Mar, 2022 | 08:14h | UTCCancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants – Journal of Clinical Oncology
Commentary: Faulty BRCA genes linked to prostate and pancreatic cancers – University of Cambridge
RCT: In operated patients with head and neck cancer, chemoradiotherapy with weekly cisplatin is noninferior to 3-weekly cisplatin and is associated with reduced toxicity.
3 Mar, 2022 | 08:11h | UTC
Commentary from the author on Twitter
Dear friends,
Finally, the results of JCOG1008, post operative CRT (weekly CDDP vs. 3-weekly CDDP) has published on Journal of Oncology.
Weekly CDDP+RT is a new treatment option with equal efficacy and better safety profile.
Please check the manuscript!!https://t.co/XG6mkGeo4Y— Naomi Kiyota, MD, PhD (@kiyota_naomi) March 1, 2022
(Epi)genetic predisposing factors found in one-third of children diagnosed with Wilms tumor.
3 Mar, 2022 | 08:10h | UTC
SEOM-GECP-GETTHI Clinical Guidelines for the treatment of patients with thymic epithelial tumors.
3 Mar, 2022 | 08:08h | UTC
Educational Review: Multiparametric MRI evaluation of bone sarcomas in children.
3 Mar, 2022 | 07:54h | UTCMultiparametric MRI evaluation of bone sarcomas in children – Insights into Imaging
SEOM clinical guidelines for the prophylaxis of infectious diseases in cancer patients.
2 Mar, 2022 | 08:51h | UTC
RCT: Referral for early, supported exercise after breast cancer surgery improves shoulder function and health-related quality of life.
1 Mar, 2022 | 08:50h | UTCFull Report: Exercise to prevent shoulder problems after breast cancer surgery: the PROSPER RCT – Health Technology Assessment
HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management.
1 Mar, 2022 | 08:30h | UTCHPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management – Nature Reviews Clinical Oncology (if the link is paywalled, try this one)
Review: CRISPR in cancer biology and therapy.
27 Feb, 2022 | 22:27h | UTCCRISPR in cancer biology and therapy – Nature Reviews Cancer (if the link is paywalled, try this one)
New treatment strategies for advanced-stage gastrointestinal stromal tumors.
27 Feb, 2022 | 22:28h | UTCNew treatment strategies for advanced-stage gastrointestinal stromal tumours – Nature Reviews Clinical Oncology (if the link is paywalled, try this one)
Commentary on Twitter
In a Review now live online, @LRberyllium, @HKhosroyani, Jason D. Kent & Michael Heinrich from the @GistLab at @OHSUKnight discuss 'New treatment strategies for advanced-stage gastrointestinal stromal tumours: https://t.co/pJ0cMuvUMG #scmsm #stcsm #esocsm #CRCSM pic.twitter.com/lMtjkAcJUZ
— NatureRevClinOncol (@NatRevClinOncol) February 25, 2022
Risk of cancer in regular and low meat-eaters, fish-eaters, and vegetarians: a prospective analysis of UK Biobank participants.
25 Feb, 2022 | 11:24h | UTCCommentaries:
Expert reaction to study looking at eating meat and risk of cancer – Science Media Centre
Low-meat and meat-free diets associated with lower overall cancer risk – Biomed Central
Commentary on Twitter
Study suggests being #vegetarian may be associated w/lower risk of #cancer
⬇️risk of #colorectalcancer in low meat 🥩 eaters consistent w/evidence of impact of meat
⬇️risk of postmenopausal #breastcancer in #vegetarian 🌱women may be explained by🔽BMIhttps://t.co/1uQfEFgoRT pic.twitter.com/VHhh9NbFSL
— Gil Morgan, MD (@weoncologists) February 25, 2022
Top advances in esophageal/gastroesophageal junction cancers in 2021.
25 Feb, 2022 | 11:01h | UTCTop advances in esophageal/gastroesophageal junction cancers in 2021 – Cancer
RCT: Arterial chemotherapy of oxaliplatin plus fluorouracil vs. sorafenib in advanced hepatocellular carcinoma.
25 Feb, 2022 | 10:53h | UTCArterial Chemotherapy of Oxaliplatin Plus Fluorouracil Versus Sorafenib in Advanced Hepatocellular Carcinoma: A Biomolecular Exploratory, Randomized, Phase III Trial (FOHAIC-1) – Journal of Clinical Oncology (link to abstract – $ for full-text)
Commentary on Twitter
FOHAIC-1 Trial: Arterial FOLFOX chemotherapy improved survival outcomes compared to sorafenib in advanced #HepatocellularCarcinoma 💉 https://t.co/coazeM6Tq5 #JCO #hpbcsm #LiverCancer #hccsm pic.twitter.com/QDWdSD4P7e
— Journal of Clinical Oncology (@JCO_ASCO) January 4, 2022
An evidence-based guideline for surveillance of patients after curative treatment for colon and rectal cancer.
25 Feb, 2022 | 10:59h | UTC
Opinion: A ‘more, more, more’ approach to cancer screening is misleading and harmful.
25 Feb, 2022 | 10:57h | UTCA ‘more, more, more’ approach to cancer screening is misleading and harmful – STAT
ASCO Report: Use of Biosimilar Medications in Oncology.
24 Feb, 2022 | 10:08h | UTCUse of Biosimilar Medications in Oncology – JCO Oncology Practice
News Release: New ASCO Report Clarifies Potential Value and Utility of Biosimilars in Oncology – ASCO Daily News
Screening Algorithms in Dense Breasts: AJR Expert Panel Narrative Review.
24 Feb, 2022 | 10:11h | UTC
M-A: Secondary cytoreductive surgery in platinum-sensitive recurrent ovarian cancer.
24 Feb, 2022 | 10:02h | UTCSecondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer: A Meta-Analysis – Journal of Clinical Oncology (link to abstract – $ for full-text)
Commentary: Meta-Analysis Affirms Survival Benefit of Second Surgery in Ovarian Cancer — Mortality decreased with rising rates of complete, optimal cytoreduction at recurrence – MedPage Today (free registration required)
Related:
RCT: Cytoreductive surgery for relapsed ovarian cancer.
A review of mucinous cystic and intraductal neoplasms of the pancreatobiliary tract: recent advances.
24 Feb, 2022 | 09:59h | UTC
AGA Guideline on systemic therapy for hepatocellular carcinoma.
23 Feb, 2022 | 10:14h | UTCAGA Clinical Practice Guideline on Systemic Therapy for Hepatocellular Carcinoma – Gastroenterology
ASCO Guideline Update: Adjuvant systemic therapy and adjuvant radiation therapy for stage I-IIIA completely resected non–small-cell lung cancer.
23 Feb, 2022 | 10:08h | UTC
Commentary on Twitter
‼️ Just published in #JCO: @ASCO rapid guideline update on adjuvant systemic therapy & adjuvant radiation therapy for stage I to IIIA completely resected #NSCLC 🫁 https://t.co/OheQi7Bi97 #lcsm #radonc pic.twitter.com/Dax2orUXZy
— Journal of Clinical Oncology (@JCO_ASCO) February 15, 2022
Opinion | Controlling the control arm in metastatic castration-resistant prostate cancer trials: best standard of care or the minimum standard of care?
23 Feb, 2022 | 10:03h | UTC
Systematic Review: Weekly versus tri‐weekly paclitaxel with carboplatin for first‐line treatment in women with epithelial ovarian cancer.
23 Feb, 2022 | 10:05h | UTC
RCT | Comparison of 3 Paclitaxel-based chemoradiotherapy regimens for patients with locally advanced esophageal squamous cell cancer.
22 Feb, 2022 | 08:19h | UTC